mRNA Leapfrogs DNA to Show Promise for Therapeutic Gene Transfer
Open Access
- 1 April 2012
- journal article
- editorial
- Published by Elsevier in Molecular Therapy
- Vol. 20 (4) , 694-695
- https://doi.org/10.1038/mt.2012.31
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding ErythropoietinMolecular Therapy, 2012
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNANucleic Acids Research, 2011
- Tumor vaccination using messenger RNA: prospects of a future therapyCurrent Opinion in Immunology, 2011
- Expression of therapeutic proteins after delivery of chemically modified mRNA in miceNature Biotechnology, 2011
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological StabilityMolecular Therapy, 2008
- Toll‐like ReceptorsPublished by Wiley ,2005
- Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNAScience, 2004
- mRNA Is an Endogenous Ligand for Toll-like Receptor 3Journal of Biological Chemistry, 2004
- Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant ErythropoietinNew England Journal of Medicine, 2002
- Induction of Anti-Tumor Immunity with Epidermal Cells Pulsed with Tumor-Derived RNA or Intradermal Administration of RNAJournal of Investigative Dermatology, 2000